6 research outputs found
Trombocitopenia induzida por heparina em paciente com oclusão arterial aguda
Resumo A trombocitopenia induzida por heparina é uma complicação grave da terapêutica anticoagulante com heparina e está associada à formação de anticorpos antifator IV plaquetário. Costuma surgir a partir do quinto dia do tratamento, com queda de pelo menos 50% da contagem plaquetária. Em decorrência da ativação plaquetária concomitante, pode ocorrer quadro de trombose, venosa ou arterial, com repercussões clínicas graves. Apresentamos um caso de paciente portador de síndrome do anticorpo antifosfolípide, com quadro de oclusão arterial aguda, que foi tratado cirurgicamente e recebeu heparina não fracionada no intra e pós-operatório. No quinto dia de tratamento anticoagulante, apresentou queda maior de 50% da contagem de plaquetas em relação à contagem pré-heparina. A suspeita de trombocitopenia induzida por heparina e seus aspectos diagnósticos e terapêuticos serão abordados neste desafio terapêutico
PCV1: A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN AS PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH ESTABLISHED PERIPHERAL ARTERY DISEASE
PCV1: A COST-EFFECTIVENESS ANALYSIS OF CLOPIDOGREL VERSUS ASPIRIN AS PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH ESTABLISHED PERIPHERAL ARTERY DISEASE
Pharmacological Evaluation of Morphine and Non-opioid Analgesic Adjuvants in a Mouse Model of Skin Cancer Pain
Health care in a technological world
Ongoing innovation in the field of mobile health (mHealth) has the potential to change the landscape of healthcare practice both inside and outside formal clinical settings. mHealth could enhance patient education, prevent disease, improve diagnosis and research-based treatment, reduce healthcare costs and enable patients to manage long-term conditions. In addition, unimpeded by geographical distance, smartphone-linked wearable sensors, built around real-time connectivity, will improve communication between health professionals and improve the understanding of physiological variability, thereby improving clinical decisions and quality of care. However, despite the potential of mHealth, there are still significant information gaps regarding its long-term effects, acceptability, costs and risks. There is therefore a significant need for continued research to evaluate the functions and appropriateness of these medical devices that are slowly entering the healthcare arena, while not neglecting the rights of the individual
